Mutation of the Von-Hippel Linda (VHL) gene, which happened in more than 70% of RCC patients, could protect RCC cells from apoptosis by preventing the degradation of hypoxia-inducible factor (HIF) [49]. The gene discussed is VHL; the disease is renal cell carcinoma.